• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

数据驱动的抗菌药物管理的数字监测:来自印度资源受限环境的过程视角

Digital monitoring for data-driven antimicrobial stewardship: a process perspective from resource-constrained contexts in India.

作者信息

Thakral Yogita

机构信息

The Health Information Systems Programme (HISP) Centre and Department of Informatics, University of Oslo, Oslo, Norway.

Society of Health Information Systems Programme, Health Information Systems Programme (HISP) India, New Delhi, India.

出版信息

Front Antibiot. 2023 Aug 2;2:1214826. doi: 10.3389/frabi.2023.1214826. eCollection 2023.

DOI:10.3389/frabi.2023.1214826
PMID:39816656
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11731685/
Abstract

Antimicrobial Resistance (AMR) is one of society's most urgent global issues, requiring urgent multidisciplinary-based research and practice approaches to engage with these policies. Several global and national policy statements have been released in the last two decades, particularly emphasising the strengthening of the digital surveillance system. However, implementing these initiatives remains patchy, particularly in the context of public health systems in Low- and Middle-Income Countries. This paper argues that one of the significant reasons contributing to this sub-optimal uptake of these systems is that the top-down implementation models do not adequately cater to the needs, aspirations, and capacities of the health facility staff, who, ultimately, are the end users of the system. The paper highlights the importance of digital technology in healthcare facilities with resource constraints to promote the responsible use of antibiotics. It discusses the process of developing an evidence base for action in low- and middle-income countries (LMICs) through digitally mediated data-driven policy. This process is conceptualised as a three-phase process, which involves stabilising data entry, generating outcomes, and taking action at the local level. The paper argues the need for bottom-up implementation models, which emphasise the need to understand the practices users engage with in their everyday work and design the digital system to add value and not work to these everyday practices. The paper emphasises the importance of building local capacities to develop effective and sustainable antimicrobial stewardship (AMS) programs through enabling networking around digital solutions, creating value in networked partnerships, initiating conversations around data, and raising awareness of the digital to develop AMS programs.

摘要

抗菌药物耐药性(AMR)是当今社会最紧迫的全球性问题之一,需要采取基于多学科的紧急研究和实践方法来落实这些政策。在过去二十年里,已经发布了多项全球和国家政策声明,特别强调加强数字监测系统。然而,这些举措的实施情况仍然参差不齐,尤其是在低收入和中等收入国家的公共卫生系统背景下。本文认为,这些系统采用率未达最优的一个重要原因是,自上而下的实施模式没有充分满足卫生机构工作人员的需求、期望和能力,而他们最终是该系统的终端用户。本文强调了数字技术在资源有限的医疗机构中对促进抗生素合理使用的重要性。它讨论了通过数字媒介驱动的数据政策在低收入和中等收入国家(LMICs)建立行动证据基础的过程。这个过程被概念化为一个三阶段过程,包括稳定数据录入、产生结果以及在地方层面采取行动。本文主张采用自下而上的实施模式,这种模式强调需要了解用户在日常工作中的行为,并设计数字系统以增加价值,而不是与这些日常行为相悖。本文强调通过围绕数字解决方案建立网络、在网络伙伴关系中创造价值、发起关于数据的对话以及提高对数字技术的认识来发展抗菌药物管理(AMS)计划,从而建设地方能力以制定有效且可持续的AMS计划的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/0d50c4bf5f3a/frabi-02-1214826-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/155acfa82463/frabi-02-1214826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/33be7b3f8c21/frabi-02-1214826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/847fab255c4d/frabi-02-1214826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/0d50c4bf5f3a/frabi-02-1214826-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/155acfa82463/frabi-02-1214826-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/33be7b3f8c21/frabi-02-1214826-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/847fab255c4d/frabi-02-1214826-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c26b/11731685/0d50c4bf5f3a/frabi-02-1214826-g004.jpg

相似文献

1
Digital monitoring for data-driven antimicrobial stewardship: a process perspective from resource-constrained contexts in India.数据驱动的抗菌药物管理的数字监测:来自印度资源受限环境的过程视角
Front Antibiot. 2023 Aug 2;2:1214826. doi: 10.3389/frabi.2023.1214826. eCollection 2023.
2
Challenges in Implementing Antimicrobial Stewardship Programmes at Secondary Level Hospitals in India: An Exploratory Study.印度二级医院实施抗菌药物管理计划面临的挑战:一项探索性研究
Front Public Health. 2020 Sep 18;8:493904. doi: 10.3389/fpubh.2020.493904. eCollection 2020.
3
Opportunities to Enhance Diagnostic Testing and Antimicrobial Stewardship: A Qualitative Multinational Survey of Healthcare Professionals.加强诊断检测和抗菌药物管理的机遇:一项针对医疗保健专业人员的定性多国调查
Infect Dis Ther. 2024 Jul;13(7):1621-1637. doi: 10.1007/s40121-024-00996-1. Epub 2024 Jun 3.
4
Implementation of hospital antimicrobial stewardship programmes in low- and middle-income countries: a qualitative study from a multi-professional perspective in the Global-PPS network.低收入和中等收入国家医院抗菌药物管理计划的实施:来自全球PPS网络多专业视角的定性研究
Antimicrob Resist Infect Control. 2025 Apr 5;14(1):26. doi: 10.1186/s13756-025-01541-6.
5
Mechanisms affecting the implementation of a national antimicrobial stewardship programme; multi-professional perspectives explained using normalisation process theory.影响国家抗菌药物管理计划实施的机制;使用规范过程理论解释多专业视角。
Antimicrob Resist Infect Control. 2020 Jul 2;9(1):99. doi: 10.1186/s13756-020-00767-w.
6
A road-map for addressing antimicrobial resistance in low- and middle-income countries: lessons learnt from the public private participation and co-designed antimicrobial stewardship programme in the State of Kerala, India.解决中低收入国家抗菌药物耐药问题的路线图:从印度喀拉拉邦公私参与和共同设计的抗菌药物管理方案中吸取的经验教训。
Antimicrob Resist Infect Control. 2021 Feb 11;10(1):32. doi: 10.1186/s13756-020-00873-9.
7
Antimicrobial Stewardship Programs in Resource Constrained Environments: Understanding and Addressing the Need of the Systems.资源受限环境中的抗菌药物管理计划:了解和满足系统需求。
Front Public Health. 2020 Apr 28;8:140. doi: 10.3389/fpubh.2020.00140. eCollection 2020.
8
Closing the antimicrobial stewardship gap - a call for LMICs to embrace the global antimicrobial stewardship accreditation scheme.缩小抗菌药物管理差距 - 呼吁中低收入国家采用全球抗菌药物管理认证计划。
Antimicrob Resist Infect Control. 2024 Feb 14;13(1):19. doi: 10.1186/s13756-024-01371-y.
9
Coverage of policies to improve antimicrobial stewardship in human medicine in low and middle income countries: results from the Global Survey of Experts on Antimicrobial Resistance.改善中低收入国家人类医学中抗菌药物管理政策的覆盖范围:来自全球抗菌药物耐药性专家调查的结果。
BMC Public Health. 2024 Aug 23;24(1):2297. doi: 10.1186/s12889-024-19542-2.
10
Strengthening antimicrobial stewardship activities in secondary and primary public healthcare facilities in India: Insights from a qualitative study with stakeholders.加强印度二级和一级公共医疗设施中的抗菌药物管理活动:来自与利益相关者的定性研究的见解
Indian J Med Microbiol. 2023 Jan-Feb;41:59-63. doi: 10.1016/j.ijmmb.2022.12.011. Epub 2023 Jan 13.

引用本文的文献

1
Antibiotic stewardship through clinical data digitization: perceived opportunities and obstructions by medical doctors from semi-urban setting in central India.通过临床数据数字化进行抗生素管理:印度中部半城市地区医生所感知到的机遇与阻碍
Front Digit Health. 2025 Sep 10;7:1652086. doi: 10.3389/fdgth.2025.1652086. eCollection 2025.

本文引用的文献

1
Delhi's network for surveillance of antimicrobial resistance: The journey, challenges and output from first year.德里抗菌药物耐药性监测网络:第一年的历程、挑战与成果
Indian J Med Microbiol. 2023 Jan-Feb;41:19-24. doi: 10.1016/j.ijmmb.2022.12.001. Epub 2022 Dec 23.
2
An analysis of existing national action plans for antimicrobial resistance-gaps and opportunities in strategies optimising antibiotic use in human populations.对现有的国家抗菌素耐药行动计划的分析——在优化人群中抗生素使用的策略方面存在的差距和机遇。
Lancet Glob Health. 2023 Mar;11(3):e466-e474. doi: 10.1016/S2214-109X(23)00019-0. Epub 2023 Feb 2.
3
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis.
2019 年全球细菌对抗菌药物耐药性的负担:系统分析。
Lancet. 2022 Feb 12;399(10325):629-655. doi: 10.1016/S0140-6736(21)02724-0. Epub 2022 Jan 19.
4
The overlooked pandemic of antimicrobial resistance.被忽视的抗微生物药物耐药性大流行。
Lancet. 2022 Feb 12;399(10325):606-607. doi: 10.1016/S0140-6736(22)00087-3. Epub 2022 Jan 19.
5
Navigating sociocultural disparities in relation to infection and antibiotic resistance-the need for an intersectional approach.应对感染与抗生素耐药性方面的社会文化差异——采用交叉性方法的必要性。
JAC Antimicrob Resist. 2021 Oct 1;3(4):dlab123. doi: 10.1093/jacamr/dlab123. eCollection 2021 Dec.
6
Surveillance of antimicrobial resistance in low- and middle-income countries: a scattered picture.中低收入国家抗菌药物耐药性监测:支离破碎的图景。
Antimicrob Resist Infect Control. 2021 Mar 31;10(1):63. doi: 10.1186/s13756-021-00931-w.
7
Investigation and control of an outbreak of urinary tract infections caused by Burkholderia cepacian-contaminated anesthetic gel.鲍曼不动杆菌污染的麻醉凝胶引起的尿路感染暴发的调查与控制。
Antimicrob Resist Infect Control. 2021 Jan 6;10(1):1. doi: 10.1186/s13756-020-00855-x.
8
Artificial intelligence and the future of global health.人工智能与全球健康的未来。
Lancet. 2020 May 16;395(10236):1579-1586. doi: 10.1016/S0140-6736(20)30226-9.
9
Will 10 Million People Die a Year due to Antimicrobial Resistance by 2050?到2050年,每年会有1000万人死于抗微生物药物耐药性吗?
PLoS Med. 2016 Nov 29;13(11):e1002184. doi: 10.1371/journal.pmed.1002184. eCollection 2016 Nov.
10
The health gap: the challenge of an unequal world.健康差距:不平等世界的挑战。
Lancet. 2015 Dec 12;386(10011):2442-4. doi: 10.1016/S0140-6736(15)00150-6. Epub 2015 Sep 9.